A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

NCT05956587 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
Nasopharyngeal Carcinoma

Interventions

DRUG: BL-B01D1
DRUG: SI-B003

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]